COROMANDEL1,966.00

Coromandel International Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersCHAMBLFERTDEEPAKFERTGSFCUPLPIINDSRFSOLARINDSPIDILITINDMcap ₹580 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations6,988.15,464.23,912.74,728.87,432.86,935.24,988.47,042.39,654.18,779.560.08,164.8
Other Income44.858.583.554.165.0113.7126.083.7116.583.20.649.8
Total Income7,032.95,522.73,996.34,782.97,497.87,048.95,114.37,126.09,770.68,862.660.78,214.6
Expenses
+ Cost of Materials Consumed3,095.33,591.62,870.22,983.03,372.23,360.33,196.43,566.94,716.94,795.141.54,615.2
+ Purchases of Stock-in-Trade496.01,124.0297.21,084.71,137.32,103.2616.82,347.11,796.72,885.78.22,667.2
+ Changes in Inventories1,527.1-391.0-346.9-586.31,057.7-164.9-306.0-675.2849.7-932.9-6.6-1,100.3
+ Employee Benefit Expense177.2185.4170.6182.2187.9204.6209.3225.4264.8285.92.7300.8
+ Finance Costs46.238.161.757.466.173.165.968.0101.883.50.989.0
+ Depreciation & Amortisation54.063.563.065.369.070.885.4120.6101.8146.61.6202.8
+ Other Expenses633.9596.3648.7559.5702.9710.4845.9795.9879.5946.09.2926.2
Total Expenses6,029.65,208.03,764.44,345.76,593.16,357.34,713.76,448.78,711.28,209.957.77,700.9
EBITDA1,058.7357.8273.0505.8974.8721.8426.0782.11,146.5799.64.9755.7
EBIT1,004.8294.3210.0440.5905.8651.0340.6661.51,044.8653.13.2552.9
Profit
PBT before Exceptional Items1,003.3314.7231.9437.2904.7691.6400.7677.31,059.5652.83.0513.7
+ Exceptional Items0.00.00.00.00.00.0346.80.00.00.0-0.70.0
Pretax Income1,003.3314.7231.9437.2904.7691.6747.5677.31,059.5652.82.3513.7
+ Current Tax244.072.558.9114.2232.4179.9147.3177.4281.5186.90.9110.5
+ Deferred Tax0.95.1-1.1-1.60.4-4.65.1-1.7-15.5-22.60.221.6
Tax Expense245.077.657.8112.5232.8175.2152.4175.7266.0164.31.1132.1
+ Share of Associates & JVs-3.8-9.0-10.2-15.4-12.9-8.5-16.6-0.00.00.0-0.00.0
Net Income754.6228.1163.9309.2659.1507.9578.5501.6793.4488.51.1381.6
+ Net Income — Continuing Ops758.4237.1174.1324.7672.0516.4595.1501.6793.4488.51.1381.6
+ Other Comprehensive Income59.7-3.9-9.11.1-1.0-1.65.1-1.027.61.40.5-11.8
Total Comprehensive Income814.3224.2154.8310.3658.2506.3583.6500.6821.0489.91.6369.7
Net Income to Common756.9231.0160.3311.0663.1511.8579.7505.0805.3505.91.4
Minority Interest-2.3-2.93.6-1.7-5.0-3.9-1.2-3.4-11.9-17.4-0.3
Per Share
Basic EPS25.727.845.4510.5722.5717.3919.7017.1527.3417.174.7512.93
Diluted EPS25.697.835.4510.5622.5317.3619.6717.1227.3017.144.7512.92
Other Comprehensive Income — detail
+ Other Comprehensive Income5.1-1.027.61.40.5-11.8
+ Items NOT to be Reclassified to P&L70.0-5.7-1.5-1.10.04.51.5-1.30.2-0.5
+ Tax on Items NOT to be Reclassified0.40.4-0.30.0-0.1
+ Tax on Items NOT to be Reclassified — alt tag7.3-1.27.7-0.30.0
+ Items to be Reclassified to P&L-2.00.90.01.5-0.2-2.31.3-0.926.52.40.4-15.8
+ Tax on Items to be Reclassified0.30.10.00.00.0-4.4
+ Tax on Items to be Reclassified — alt tag1.00.2-0.10.4-0.0-0.7
Comprehensive Income — Owners of Parent816.6227.1151.2312.1-1.0-1.65.1-0.720.5506.71.8
Comprehensive Income — Non-controlling Interests-2.3-2.93.6-1.70.00.00.1-0.37.1-16.8-0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations25.727.845.4510.5722.5717.3919.7017.1527.3417.174.7512.93
Diluted EPS — Continuing Operations25.697.835.4510.5622.5317.3619.6717.1227.3017.144.7512.92
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,869.81,139.51,092.31,247.51,865.61,636.71,481.21,803.52,290.82,031.516.81,982.7
Gross Margin %26.7620.8527.9226.3825.1023.6029.6925.6123.7323.1428.0624.28
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)1,003.3314.7231.9437.2904.7691.6400.7677.31,059.5652.83.0513.7
− Exceptional Items (reconciliation)0.00.00.00.00.00.0346.80.00.00.0-0.70.0
Net Income Adj (tax-effected)754.6228.1163.9309.2659.1507.9302.4501.6793.4488.51.5381.6
EPS Adj25.727.845.4510.5722.5717.3910.3017.1527.3417.176.2212.93
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.001.001.001.001.001.001.001.001.00
Paid Up Equity Capital29.429.429.429.529.529.529.529.529.529.50.329.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 94%.